Christopher S. Lathan

7.0k total citations · 2 hit papers
87 papers, 4.1k citations indexed

About

Christopher S. Lathan is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher S. Lathan has authored 87 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 29 papers in Economics and Econometrics and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher S. Lathan's work include Global Cancer Incidence and Screening (34 papers), Economic and Financial Impacts of Cancer (27 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Christopher S. Lathan is often cited by papers focused on Global Cancer Incidence and Screening (34 papers), Economic and Financial Impacts of Cancer (27 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Christopher S. Lathan collaborates with scholars based in United States, United Kingdom and Italy. Christopher S. Lathan's co-authors include John Z. Ayanian, M. Elizabeth Paulk, Holly G. Prigerson, Susan D. Block, Tracy A. Balboni, John R. Peteet, Lauren C. Vanderwerker, S. Yousuf Zafar, Craig C. Earle and Bridget A. Neville and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Christopher S. Lathan

82 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Religiousness and Spiritual Support Among Advanced Cancer Patients and Associations With End-of-Life Treatment Preferences and Quality of Life

2007 700 citations M. Elizabeth Paulk, Christopher S. Lathan et al. Journal of Clinical Oncology profile →
Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline

2017 358 citations Timothy D. Gilligan, Nessa Coyle et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher S. Lathan United States	28	1.5k	1.1k	774	748	734	87	4.1k
Pascale Grosclaude France	36	2.5k 1.7×	528 0.5×	390 0.5×	1.1k 1.5×	375 0.5×	206	5.7k
Sharon B. Murphy United States	39	1.3k 0.9×	1.4k 1.2×	183 0.2×	483 0.6×	468 0.6×	112	4.5k
Enrique Soto‐Pérez‐de‐Celis Mexico	30	1.7k 1.1×	842 0.8×	618 0.8×	628 0.8×	211 0.3×	194	3.8k
Clement K. Gwede United States	36	1.9k 1.3×	1.4k 1.2×	372 0.5×	2.0k 2.6×	193 0.3×	177	5.9k
Sally L. Glaser United States	50	3.9k 2.6×	859 0.8×	213 0.3×	450 0.6×	287 0.4×	115	6.1k
Timothy S. McNeel United States	37	2.9k 2.0×	834 0.7×	729 0.9×	523 0.7×	253 0.3×	98	5.5k
Anthony P. Polednak United States	33	1.2k 0.8×	425 0.4×	217 0.3×	548 0.7×	267 0.4×	195	3.8k
Barry A. Miller United States	26	2.2k 1.5×	454 0.4×	294 0.4×	561 0.8×	205 0.3×	40	3.9k
Michele R. Hacker United States	38	318 0.2×	1.5k 1.3×	224 0.3×	307 0.4×	332 0.5×	303	5.7k
Anne C. Kirchhoff United States	35	1.3k 0.9×	1.4k 1.2×	1.1k 1.4×	413 0.6×	85 0.1×	197	4.7k

Countries citing papers authored by Christopher S. Lathan

Since Specialization

Citations

This map shows the geographic impact of Christopher S. Lathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Lathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Lathan more than expected).

Fields of papers citing papers by Christopher S. Lathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Lathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Lathan. The network helps show where Christopher S. Lathan may publish in the future.

Co-authorship network of co-authors of Christopher S. Lathan

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Lathan. A scholar is included among the top collaborators of Christopher S. Lathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Lathan. Christopher S. Lathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yating, Angel M. Cronin, Elad Sharon, et al.. (2025). Duffy Null–Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility. JAMA Oncology. 11(12). 1540–1540. 1 indexed citations

Vega, Eduardo A., Christopher S. Lathan, George P. Sorescu, et al.. (2024). Temporal trends of health disparity in the utilization of curative-intent treatments for hepatocellular carcinoma: are we making progress?. Journal of Gastrointestinal Surgery. 28(9). 1392–1399.

Hofferberth, Sophie C., et al.. (2023). Restructuring lung cancer care to accelerate diagnosis and treatment in patients vulnerable to healthcare disparities using an innovative care model. MethodsX. 11. 102338–102338.

Roberts, Daniel A., K. Leahy, Sara Giordano, et al.. (2022). Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the Future. JCO Oncology Practice. 19(6). e927–e934. 5 indexed citations

Chen, Moon S., Karriem S. Watson, Vida Henderson, et al.. (2021). Recommendations from a Dialogue on Evolving National Cancer Institute-Designated Comprehensive Cancer Center Community Outreach and Engagement Requirements: A Path Forward. Health Equity. 5(1). 76–83. 9 indexed citations

Kutlu, Onur, Eduardo A. Vega, Christopher S. Lathan, et al.. (2020). Laparoscopic pancreatectomy for cancer in high volume centers is associated with an increased use and fewer delays of adjuvant chemotherapy. HPB. 23(4). 625–632. 14 indexed citations

Chau, Nicole G., Clement Ma, Hasan Al‐Sayegh, et al.. (2019). An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients. JNCI Cancer Spectrum. 4(2). pkz094–pkz094. 131 indexed citations

Perez, Giselle K., Ilana F. Gareen, JoRean D. Sicks, et al.. (2019). Racial Differences in Smoking-related Disease Risk Perceptions Among Adults Completing Lung Cancer Screening: Follow-up Results from the ACRIN/NLST Ancillary Study. Journal of Racial and Ethnic Health Disparities. 6(4). 676–685. 6 indexed citations

Hofferberth, Sophie C., Sam Fox, Paul Catalano, et al.. (2019). PD01.19 Lung Cancer Strategist Program: a Novel Care Delivery Model to Improve Timeliness of Diagnosis and Treatment. Journal of Thoracic Oncology. 14(11). S1140–S1140. 1 indexed citations

10.

Kwon, Misol, et al.. (2019). Access to Cancer Care Resources in a Federally Qualified Health Center: a Mixed Methods Study to Increase the Understanding of Met and Unmet Needs of Cancer Survivors. Journal of Cancer Education. 36(3). 591–602. 2 indexed citations

11.

Gilligan, Timothy D., Nessa Coyle, Richard M. Frankel, et al.. (2018). Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline. Obstetrical & Gynecological Survey. 73(2). 96–97. 26 indexed citations

12.

Lathan, Christopher S., Angel M. Cronin, Reginald Tucker‐Seeley, et al.. (2016). Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer. Journal of Clinical Oncology. 34(15). 1732–1740. 294 indexed citations

13.

Lathan, Christopher S.. (2015). Lung Cancer Disparities in the Era of Personalized Medicine. 11(2). 3 indexed citations

14.

Sholl, Lynette M., Mizuki Nishino, Saraswati Pokharel, et al.. (2015). Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations. Journal of Thoracic Oncology. 10(6). 951–959. 89 indexed citations

15.

Mahal, Brandon A., David R. Ziehr, Ayal A. Aizer, et al.. (2014). Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Urologic Oncology Seminars and Original Investigations. 32(8). 1285–1291. 71 indexed citations

16.

Mahal, Brandon A., David R. Ziehr, Ayal A. Aizer, et al.. (2014). Racial disparities in an aging population: The relationship between age and race in the management of African American men with high-risk prostate cancer. Journal of Geriatric Oncology. 5(4). 352–358. 20 indexed citations

17.

Jimenez, Rachel, Baohui Zhang, Steven Joffe, et al.. (2013). Clinical Trial Participation among Ethnic/Racial Minority and Majority Patients with Advanced Cancer: What Factors Most Influence Enrollment?. Journal of Palliative Medicine. 16(3). 256–262. 26 indexed citations

18.

Lynch, Julie A., Muin J. Khoury, Ann M. Borzecki, et al.. (2013). Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research. Genetics in Medicine. 15(8). 630–638. 26 indexed citations

19.

Abel, Gregory A., et al.. (2013). A novel community-based delivery model to combat cancer disparities. Healthcare. 1(3-4). 123–129. 4 indexed citations

20.

Bauer, Daniel E., Chelsey M. Mitchell, Kelly M. Strait, et al.. (2012). Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma. Clinical Cancer Research. 18(20). 5773–5779. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact